Nucleus Genomics lands new funding from Alexis Ohanian to help people assess specific disease risks

Nucleus Genomics lands new funding from Alexis Ohanian to help people assess specific disease risks

Nucleus Genomics, a genetic testing company focused on calculating a patient’s risk of certain diseases, is adding $14 million to their initial seed funding round. With this round the company has raised, in total, $17.5 million. This “seed plus” funding round was led by Alexis Ohanian’s 776. Ohanian is joining investors like Founders Fund, Adrian […]

This content has been restricted to logged in users only. Please login to view this content.